Spot on Biotechnology Business 2018/2019
Total Page:16
File Type:pdf, Size:1020Kb
Online Company Company Database Directory www.bio.nrw.de BIO.NRW Merowingerplatz 1 40225 Düsseldorf, Germany Fon +49 211 385469-9200 Fax +49 211 385469-9220 [email protected] www.bio.nrw.de Ministry of Economic Affairs, Innovation, Digitization and Energy of the State of North Rhine-Westphalia 40213 Düsseldorf www.wirtschaft.nrw www.bio.nrw.de Spot on Biotechnology Business 2018/2019 From Mind to Market: Biotechnology Company Directory 2018/2019 North Rhine-Westphalia BIO.NRW 4 BIO.NRW Editorial Dear Reader, cessful ecosystems that risk capital is a key factor. As state politicians, however, we must North Rhine-Westphalia plays a leading also endeavor to exert a positive influence on role in biotechnology – one of the key tech- factors such as the prestige of entrepreneur- nologies of this century. In 2017, sales of ship, risk culture in general and the provision the North Rhine-Westphalian biotech sector of appropriate skills for company start-ups. rose by around 15 percent to more than 2 Contact between start-ups and corporates billion euros. This means that biotechnology must become a matter of course. in NRW accounted for more than half of the We have set up a “NRW Pharma Dialogue” industry’s sales in Germany. Biopharma- in which experts from industry, science and ceutical therapy options are particularly associations develop action recommenda- important in the treatment of cancer and tions for NRW as a pharmaceutical and bio- other age-related diseases. Important im- tech location and expand on digitization as petus within the industry is provided by the an outstanding cross-sectoral topic. two leading companies Qiagen and Milte- Right at the beginning of this legislative pe- nyi, which are both based in North Rhine- riod, we approved additional venture capital Westphalia. As a cross-sectional scientific of 214 million euros for NRW.Bank’s seed and area, the impact of biotechnology extends start-up investments, thereby increasing the far beyond the life science sector. volume by 85 percent. From my work as Minister for Innovation, In order to strengthen the research power Science, Research and Technology between and start-up culture at universities and 2005 and 2010, I am also aware of the enor- ultimately the entire regional start-up eco- mous importance of our science and research system, we are going to support the estab- landscape for the further development of the lishment of Excellence Start-up Centers with industry. In 2009, at the beginning of the Bio- We will continue to systematically strengthen up to 150 million euros. The goal is to make Cluster activities, I was already in a position the research priorities developed by uni - North Rhine-Westphalia the number one to present North Rhine-Westphalia at the versities and research institutions on their start-up state. industrial fair BIO International Convention in own initiative. In order to support research Our key biotechnology sector will clearly Atlanta as a top location for biotechnological activities by industry, we have launched a benefit from these and other measures im- research. With 25 universities and colleges Bundesrat initiative to promote tax breaks plemented by the state government in the and 30 other research institutes focusing for research, in addition to project funding. coming years. on life sciences, we had and still have an North Rhine-Westphalia is already a state extraordinarily strong and diverse teaching with new ideas, innovative start-ups and a and research program. lively founders’ scene – something we want Despite the positive development of the to expand on further. industry we are not sitting back and taking What is particularly close to my heart is things easy but have formulated our ambi- the strengthening of the start-up culture tious goal in the coalition agreement to be- through better framework conditions for new Prof Dr Andreas Pinkwart come the frontrunner in biotechnology. We businesses and their founders. More than have described the measures by which we ever, we need a new “Gründerzeit” in North Minister of Economic Affairs, Innovation, intend to achieve this goal. I would now like Rhine-Westphalia. It has emerged from many Digitalization and Energy of the State of to highlight a few of them. discussions at home and abroad on suc - North Rhine-Westphalia 5 BIO.NRW 6 BIO.NRW Greeting Dear Reader, ther into the growth phase through EU and global cooperation. One of the next steps is In this ninth edition of the “Spot on Bio - our move to China with the new cooperation technology Business” brochure, I would project “ChInValue”. Additional potential of- like to look back on the development of the fered by bioinformatics and artificial intelli- biotechnology hot spot region NRW over the gence facilitates fields of action for the future. past 10 years and will be addressing some For NRW-based companies, I would like to see topics for the future. more readiness for intensive collaboration as BIO.NRW was launched at the beginning more risk-taking is needed in order to lever- of 2009 as part of the cluster policy of the age synergy potential. In general, we will have then state government. In May 2009, I ac- to develop ways to make the ecosystem even companied the Minister for Innovation, Sci- more closely interlinked in order to expand ence, Research and Technology, Professor the sustainable BIO.NRW network. Therefore, Pinkwart, to the world’s largest biotechnol- we are also looking forward to suggestions ogy trade fair “BIO International Conven- and initiatives from the community with tion” in Atlanta (USA). Biotechnology was regard to the coming years. one of four fields of technology on which Insufficient VC financing also remains a the Ministry of Innovation in NRW concen- considerable hurdle for NRW. We will there- trated its research funding. In retrospect, stakeholders. We support technology trans- fore carry on with our toolbox of financing the this was the right move. Biotech industry fer, particularly for biotech start-ups, with start-ups. 49% of all venture capital-backed sales in Germany grew from 2,184 billion coaching and financing. biotech investments in Europe in 2016 were euros in 2009 to 4,105 billion euros in 2017, One highlight is our annual International made in the UK and Switzerland (EY Bio - an increase of 88 %, more than twice as BIO.NRW Business Angel Congress. The aim technology Report 2017 Beyond borders). In much as the gross domestic product (36 %) is to supply the highly diverse investors’ com- order to break the bottleneck of structural in the comparison period. munity of business angels, venture capital- underfinancing, we would finally like to see Our activities at BIO.NRW have grown ists, institutional investors and their potential more concise and sustainable solutions from continuously over the years and the umbrel- clients with the most up-to-date finance and those responsible in the finance, economics la brand BIO.NRW is now firmly established investment information. NUMAFERM GmbH and science ministries in Berlin, especially in in science and industry. We view ourselves from Düsseldorf is a current success story regard to taxing investments. as a central dialogue platform between which was financed by participants in our business, research, investors and politics. Business Angel Circle and has just been voted This means that we take part in national and one of “Germany’s Start-up Kings” (“Bilanz” international fairs, exhibitions, and confer- business magazine). NUMAFERM’s patented ences. We analyze the biotechnology sector process can reduce the production costs of in North Rhine-Westphalia in terms of busi- peptides substantially and ecologically and ness data as well as conducting marketing be applied to all the various biotech sectors. and PR. We offer the promotion of young This is a perfect example of NRW acting as a Dr. Bernward Garthoff academics and online job platforms. Our biotech hot spot! However, further efforts are Cluster BIO.NRW focus is on collaboration with organiza - needed to consolidate the positive develop- tions such as EIT Health and with both lo- ment in the state. Representative for Biotechnology of the cal and international companies, research After an implementation and expansion German State of North Rhine-Westphalia institutions, financiers and other biotech phase, BIO.NRW will develop its network fur- 7 BIO.NRW © 2019, BIO.NRW “Spot on Biotechnology Business”, www.bio.nrw.de Print: Schloemer & Partner GmbH, Düren Design and Layout: it’s FR!TZ, Heiko Fritz, Zossen Picture Source: p. 4 © Düsseldorf Marketing and Tourismus p. 5 © MWIDE NRW/Roberto Pfeil p. 6 © Düsseldorf Marketing and Tourismus p. 10 © OlegDoroshin - stock.adobe.com p. 12 © bogdanhoda - istockphoto.com p. 14 © Eisenhans - stock.adobe.com p. 16 © BIO.NRW - Institute of Biochemistry, University of Cologne p. 18 © shironosov - istockphoto.com p. 20 © BIO.NRW - Institute of Biochemistry, University of Cologne p. 22 © Chodyra Mike - stock.adobe.com p. 28 © BillionPhotos.com - stock.adobe.com p. 38 © luchschen - istockphoto.com p. 52 © auremar - stock.adobe.com p. 57 © auremar - stock.adobe.com p. 58 © Robert Przybysz - stock.adobe.com p. 62 © kentoh - stock.adobe.com p. 65 © Gio_tto - istockphoto.com p. 66 © BillionPhotos.com - stock.adobe.com 8 BIO.NRW Content Editorial… ……………………………………………………………………………… …5 Company…Directory…2018/2019…NRW Greeting… ……………………………………………………………………………… …7 Non-specific Services …………………………………………………… 28 Spot…on…Biotechnology…Business… ………………………………… 11 Health and Medicine